pI: 8.8908 |
Length (AA): 259 |
MW (Da): 29267 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 4
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There is 1 model calculated for this protein. More info on
this model, including the
model itself is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
104 | 244 | 3rvy (A) | 1040 | 1144 | 33.00 | 0.75 | 0.05 | 0.266702 | 2.67 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, intra-erythrocytic - 48 hs, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Ring. | Otto TD PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | gametocyte, Oocyst, Sporozoite. | PlasmoDB Zanghi G |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Male Gametocyte. | Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Female Gametocyte. | Lasonder E |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_128885)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G56020 | Got1/Sft2-like vescicle transport protein |
Arabidopsis thaliana | AT4G26550 | Got1/Sft2-like vescicle transport protein |
Babesia bovis | BBOV_III001610 | SFT-2 like family protein |
Candida albicans | CaO19.2342 | one of two genes similar to S. cerevisiae SFT2 (YBL102W) involved in Golgi to endosome transport |
Candida albicans | CaO19.9878 | one of two genes similar to S. cerevisiae SFT2 (YBL102W) involved in Golgi to endosome transport |
Candida albicans | CaO19.10694 | one of two genes similar to S. cerevisiae SFT2 (YBL102W) involved in Golgi to endosome transport |
Candida albicans | CaO19.3184 | one of two genes similar to S. cerevisiae SFT2 (YBL102W) involved in Golgi to endosome transport |
Caenorhabditis elegans | CELE_C18E9.10 | Protein C18E9.10 |
Cryptosporidium hominis | Chro.60084 | hypothetical protein |
Cryptosporidium parvum | cgd6_630 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0290341 | hypothetical protein |
Drosophila melanogaster | Dmel_CG33635 | CG33635 gene product from transcript CG33635-RA |
Echinococcus granulosus | EgrG_000896200 | SFT2 |
Echinococcus multilocularis | EmuJ_000896200 | SFT2 |
Homo sapiens | 84826 | SFT2 domain containing 3 |
Loa Loa (eye worm) | LOAG_10629 | hypothetical protein |
Mus musculus | ENSMUSG00000044982 | SFT2 domain containing 3 |
Neospora caninum | NCLIV_010970 | hypothetical protein |
Oryza sativa | 4340821 | Os06g0300300 |
Oryza sativa | 4341495 | Os06g0608600 |
Onchocerca volvulus | OVOC10116 |
|
Plasmodium berghei | PBANKA_1337200 | protein transport protein SFT2, putative |
Plasmodium falciparum | PF3D7_1321800 | protein transport protein SFT2, putative |
Plasmodium knowlesi | PKNH_1207000 | protein transport protein SFT2, putative |
Plasmodium vivax | PVX_116780 | protein transport protein SFT2, putative |
Plasmodium yoelii | PY06857 | hypothetical protein |
Saccharomyces cerevisiae | YBL102W | Sft2p |
Schistosoma japonicum | Sjp_0209880 | Protein transport protein SFT2, putative |
Schistosoma mansoni | Smp_067780 | hypothetical protein |
Schmidtea mediterranea | mk4.004710.04 | |
Schmidtea mediterranea | mk4.008996.00 | |
Trypanosoma brucei gambiense | Tbg972.3.2920 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.3.2850 | Got1/Sft2-like family, putative |
Trypanosoma congolense | TcIL3000_3_1750 | hypothetical protein, conserved |
Trypanosoma cruzi | TcCLB.508153.810 | Got1/Sft2-like family, putative |
Toxoplasma gondii | TGME49_318570 | SFT2 family protein |
Theileria parva | TP03_0679 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_290870 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.2850 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.2850 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.2850 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.2850 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_C18E9.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C18E9.10 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_C18E9.10 | Caenorhabditis elegans | slow growth | wormbase |
CELE_C18E9.10 | Caenorhabditis elegans | sterile | wormbase |
YBL102W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_1337200 | Plasmodium berghei | Dispensable | plasmo |
TGME49_318570 | Toxoplasma gondii | Essentiality uncertain | sidik |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.